News & Events

News

July 11, 2019

Inclement Weather Alert

The impact of the budding hurricane, Tropical Storm Barry, on the Gulf of Mexico region is expected to be significant and may affect our pharmacy operations and delivery in limited areas.

July 3, 2019

Now Dispensing XPOVIO™

Onco360 is selected as 1 of 3 specialty pharmacies to dispense XPOVIO™ (selinexor).

June 5, 2019

Ron Bookman Scholarship Announced

The National Association of Specialty Pharmacy (NASP) has announced a scholarship program created in memory of our friend and colleague, Ron Bookman.

March 10, 2019

In Loving Memory

It is with great sadness that we announce the passing of our friend and colleague, Ron Bookman, on March 5, 2019.

November 30, 2018

Onco360 was selected as 1 of only 3 Specialty Pharmacy providers to dispense XOSPATA® (Gilteritinib) for the treatment of patients with relapsed or refractory FMS-like Tyrosine Kinase 3 (FLT3) mutation-positive acute myeloid leukemia (AML).

November 1, 2018

Dispensing Talzenna + Vizimpro

Talzenna® and Vizimpro® available now through Onco360 Oncology Specialty Pharmacy.

October 3, 2018

Exclusive Provider for Libtayo

Onco360 Selected as the Exclusive Specialty Pharmacy for Libtayo® (cemiplimab-rwlc) Limited Distribution Pharmacy Network.

July 2, 2018

Braftovi + Mektovi Available Now

Onco360 selected to participate in the limited distribution network for Array Biopharma’s new products BRAFTOVI™ (encorafenib) and MEKTOVI® (binimetinib) for the treatment of patients with unresectable or metastatic melanoma with a BRAFV600E or BRAFV600K mutation, as detected by an FDA-approved test.

March 22, 2018